非标准化高强度透析剂量改善了末期病患者的生存率
Diana D Nenova1,2, Yanko G Yankov3,4, Gergana M Chausheva5,6
1Clinic of Nephrology and Dialysis, University Hospital St. Marina, Varna, BGR.
Cureus
|November 18, 2024
概括
更高的透析剂量 (单个池Kt/V≥1.5) 提高了血液透析患者的存活率,降低了死亡风险. 仔细监测营养状况对于个性化护理和更好的临床结果至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 血液透析 (HD) 的充分性对患者的生活质量,存活率和死亡率至关重要.
- 标准HD剂量定义为单个池Kt/V (spKt/V) >1.2,但越来越多地讨论更高剂量 (spKt/V ≥1.5) 改善生存率.
- 极高的spKt/V值可能是误导性的,可能表明营养不良和死亡风险增加.
研究的目的:
- 评估非标准化高透析剂量 (spKt/V>1.5) 对血液透析患者年生存率和死亡率的影响.
- 通过个性化患者护理,探索提高生活质量和生存的策略.
- 促进在临床实践中定期实施高剂量透析方案.
主要方法:
- 在5年内对100名血液透析患者进行了回顾性生存分析.
- 根据透析剂量,患者被分为三个组:充足 (spKt/V = 1.2-1.49),高 (spKt/V ≥1.5) 和不足 (spKt/V ≤1.19).
- 分析包括全年死亡率,存活率,相对死亡风险和预期存活率.
主要成果:
- 高强度HD疗法 (spKt/V ≥1.5) 与标准疗法相比,死亡风险明显降低,预期存活时间增加.
- 增加透析剂量 (spKt/V ≥1.5) 对生存的长期益处在第三年后变得明显.
- 营养状况参数和透析足够性的指标被确定为患者预后的关键风险因素.
结论:
- 建议达到高透析剂量 (spKt/V ≥1.5),以改善脏病学中的临床结果和患者预后.
- 评估透析的充分性是复杂的,超出spKt/V值,包括营养状况监测和HD并发症的管理.
- 个性化护理和风险评估对于优化血液透析治疗和患者生存至关重要.
相关概念视频
01:27Dialysis
269
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
01:11Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
01:22Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
01:17Factors Affecting Renal Clearance: Renal Impairment
57
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
57
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
01:19Nonlinear Pharmacokinetics: Overview
282
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
282